Advertisement

Y-90 Radiomicrosphere Therapy of Colorectal Cancer: Liver Metastases

  • Seza A. Gulec
  • Tushar C. Barot
Reference work entry

Abstract

Our objective is to discuss the basic concepts involved in the development of yttrium-90 (Y-90) microsphere selective internal radiation treatment (SIRT) and review the clinical data pertaining to its application in hepatic colorectal cancer metastases. Selective internal radiation treatment is a promising new modality in the treatment of patients with hepatic colorectal cancer metastases as part of a multimodality approach. A chemoselective internal radiation treatment neoadjuvant approach has the potential to improve therapeutic outcomes. Clinical studies in neoadjuvant and salvage settings are needed for more concrete outcome data and design of optimal multimodality treatment strategies. This chapter will discuss the principles of Y-90 therapy, pretreatment evaluation of patients including various imaging techniques, treatment technique studies, and potential complications of radiomicrosphere therapy. It will also review studies previously done in the field of radiomicrosphere therapy.

Keywords

Portal Vein Embolization Future Liver Remnant Radiation Pneumonitis Resin Microsphere Salvage Setting 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Ingold JA, Reed GB, Kaplan HS, et al. Radiation hepatitis. Am J Roentgenol Radium Ther Nucl Med. 1965;93:200–8.PubMedGoogle Scholar
  2. 2.
    Gray BN, Burton MA, Kelleher D, et al. Tolerance of the liver to the effects of Yttrium-90 radiation. Int J Radiat Oncol Biol Phys. 1990;18:619–23.CrossRefPubMedGoogle Scholar
  3. 3.
    Dancey JE, Shepherd FA, Paul K, et al. Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres. J Nucl Med. 2000;41:1673–81.PubMedGoogle Scholar
  4. 4.
    Gray B, et al. Randomized trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol. 2001;12:1711–20.CrossRefPubMedGoogle Scholar
  5. 5.
    Van Hazel G, et al. Randomized phase 2 trial of SIR-Spheres plus Fluorouracil/Leucovorin chemotherapy versus Fluorouracil/Leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol. 2004;88:78–85.CrossRefPubMedGoogle Scholar
  6. 6.
    Van HG, et al. Selective internal radiation therapy (RMT) plus systemic chemotherapy with irinotecan. A phase I dose escalation study. ASCO GI Symposium 2005.Google Scholar
  7. 7.
    Van HG, et al. Selective internal radiation therapy (RMT) plus systemic chemotherapy with oxaliplatin, 5-fluorouracil and leucovorin: a phase I dose escalation study. ASCO GI Symposium 2005.Google Scholar
  8. 8.
    Gulec SA, Pennington K, Bruetman D, et al. Yttrium 90 microsphere selective internal radiation therapy with chemo therapy (chemo-SIRT) for colorectal cancer liver metastases; a phase II trial. (Manuscript Submitted for publication).Google Scholar
  9. 9.
    Kennedy A, Coldwell D, Nutting C, et al. Resin Y-90-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience. Int J Radiat Oncol Biol Phys. 2006;65(2):412–25. doi:10.1016/j.ijrobp. 2005.12.051.CrossRefPubMedGoogle Scholar
  10. 10.
    Ricke J, Rühl R, Seidensticker M, et al. Extensive liver-dominant colorectal (CRC) metastases failing multiple lines of systemic chemotherapy treated by 90Y Radioembolisation: a matched-pair analysis. Poster presentation, 11th World Congress of Gastrointestinal Cancer. Ann Oncol. 2009;20(Suppl 6:vi24):Abs. PD-002.Google Scholar
  11. 11.
    Folprecht G, Grothey A, Alberts S, et al. Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. Ann Oncol. 2005;16:1311–9.CrossRefPubMedGoogle Scholar
  12. 12.
    Cosimelli M, Golfieri R, Cagol PP, et al. Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases. Br J Cancer. 2010;103(3):324–31.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Jakobs TF, Hoffmann RT, Dehm K, et al. Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases. J Vasc Interv Radiol. 2008;19:1187–95.CrossRefPubMedGoogle Scholar
  14. 14.
    Gulec SA, Pennington K, Hall M, Fong Y. Preoperative Y-90 microsphere selective internal radiation treatment for tumor downsizing and future liver remnant recruitment: a novel approach to improving the safety of major hepatic resections. World J Surg Oncol. 2009;7:6.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Gray BN. Colorectal cancer: the natural history of disseminated disease. Aust N Z J Surg. 1980;50:643–6.CrossRefPubMedGoogle Scholar
  16. 16.
    Fong Y. Surgical therapy of hepatic colorectal metastasis. CA Cancer J Clin. 1999;49:231–55.CrossRefPubMedGoogle Scholar
  17. 17.
    Alberts SR, Horvath WL, Sternfeld WC, et al. Oxaliplatin, Fluorouracil, and Leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Cdentral Cancer Treatment Group Phase II Study. J Clin Oncol. 2005;23:9243–9.CrossRefPubMedGoogle Scholar
  18. 18.
    Bismuth H, Adam R. Reduction of non-resectable liver metastases from colorectal cancer after Oxaliplatin chemotherapy. Semin Oncol. 1998;25:40–6.PubMedGoogle Scholar
  19. 19.
    Delanoult T, Alberts SR, Sargent DJ, et al. Chemotherapy permits resection of metastatic colorectal cancer: experience from intergroup N9741. Ann Oncol. 2005;16:425–9.CrossRefGoogle Scholar
  20. 20.
    Adam R, Delvart V, Pascal G, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg. 2004;240:644–57.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of Surgical OncologyThe Herbert Wertheim College of Medicine Florida International UniversityMiamiUSA
  2. 2.Mount Sinai Medical CenterMiami BeachUSA

Personalised recommendations